We are live on ! Find out more
ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Achillion Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 129 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 132 → 0 (-132)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $755M → $0 (-$755M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 129

Holders
–
Holders Change
-132
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
129
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$79M
2
BlackRock
BlackRock
New York
-$68.8M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$45.8M
4
VI
Versor Investments
New York
-$45.3M
5
PCM
Pentwater Capital Management
Florida
-$45.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
76
Wells Fargo
California
– -$509K -84,506 Closed
Manulife (Manufacturers Life Insurance)
77
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$498K -82,668 Closed
State Board of Administration of Florida Retirement System
78
State Board of Administration of Florida Retirement System
Florida
– -$454K -75,246 Closed
CC
79
Centiva Capital
New York
– -$452K -75,000 Closed
JP Morgan Chase
80
JP Morgan Chase
New York
– -$445K -73,726 Closed
VOYA Investment Management
81
VOYA Investment Management
Georgia
– -$401K -66,434 Closed
VEA
82
Virtus ETF Advisers
New York
– -$397K -65,813 Closed
PP
83
Paloma Partners
Connecticut
– -$395K -65,585 Closed
WAM
84
Wolverine Asset Management
Illinois
– -$380K -63,091 Closed
Voloridge Investment Management
85
Voloridge Investment Management
Florida
– -$374K -62,079 Closed
GC
86
Guggenheim Capital
Illinois
– -$353K -58,530 Closed
MIM
87
MetLife Investment Management
New Jersey
– -$311K -51,647 Closed
Citadel Advisors
88
Citadel Advisors
Florida
– -$309K -51,221 Closed
ProShare Advisors
89
ProShare Advisors
Maryland
– -$294K -48,765 Closed
Deutsche Bank
90
Deutsche Bank
Germany
– -$275K -45,651 Closed
Victory Capital Management
91
Victory Capital Management
Texas
– -$262K -43,512 Closed
BAM
92
Blueshift Asset Management
New Jersey
– -$256K -42,393 Closed
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
– -$214K -35,522 Closed
PCM
94
Prelude Capital Management
New York
– -$203K -33,635 Closed
Legal & General Group
95
Legal & General Group
United Kingdom
– -$195K -32,260 Closed
Squarepoint
96
Squarepoint
New York
– -$169K -28,005 Closed
RJA
97
Raymond James & Associates
Florida
– -$164K -27,216 Closed
Public Employees Retirement Association of Colorado
98
Public Employees Retirement Association of Colorado
Colorado
– -$164K -27,160 Closed
HighTower Advisors
99
HighTower Advisors
Illinois
– -$163K -26,948 Closed
SG Americas Securities
100
SG Americas Securities
New York
– -$159K -26,448 Closed
2 3
4
5 6

ACHN Hedge Fund Activity: Q1 2020 in Review

0 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q1 2020, worth a combined $0 — down 100% from $755M a quarter earlier.

Sellers outnumbered buyers: 129 funds closed out of ACHN and 0 opened new positions — a net loss of 129 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $79M sold.

  • 0 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q1 2020, down from 132 in Q4 2019.
  • Funds reported $0 of Achillion Pharmaceuticals stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Achillion Pharmaceuticals positions in Q1 2020 and 129 closed out, a net change of -129 holders.
  • The largest Achillion Pharmaceuticals seller in Q1 2020 was Vanguard Group, an estimated $79M sold.

Based on aggregated 13F filings for Q1 2020.